Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) FCF Margin (2018 - 2025)

Historic FCF Margin for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to 419.92%.

  • Cue Biopharma's FCF Margin fell 1943200.0% to 419.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 419.97%, marking a year-over-year decrease of 179300.0%. This contributed to the annual value of 391.89% for FY2024, which is 3360000.0% up from last year.
  • Cue Biopharma's FCF Margin amounted to 419.92% in Q3 2025, which was down 1943200.0% from 116.52% recorded in Q2 2025.
  • In the past 5 years, Cue Biopharma's FCF Margin ranged from a high of 116.52% in Q2 2025 and a low of 49665.38% during Q2 2022
  • Its 5-year average for FCF Margin is 4282.05%, with a median of 573.03% in 2024.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by -492994800bps in 2022, then skyrocketed by 489149500bps in 2023.
  • Cue Biopharma's FCF Margin (Quarter) stood at 128.96% in 2021, then crashed by -5300bps to 6963.58% in 2022, then surged by 91bps to 601.76% in 2023, then grew by 5bps to 572.97% in 2024, then rose by 27bps to 419.92% in 2025.
  • Its last three reported values are 419.92% in Q3 2025, 116.52% for Q2 2025, and 1976.72% during Q1 2025.